ARGS - Argos Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.22M
Enterprise Value 33.6M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.16
Price/Book (mrq)N/A
Enterprise Value/Revenue 30.47
Enterprise Value/EBITDA 6-0.17

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin -240.82%
Operating Margin (ttm)-288.33%

Management Effectiveness

Return on Assets (ttm)-53.55%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)7.73M
Revenue Per Share (ttm)1.75
Quarterly Revenue Growth (yoy)5,536.50%
Gross Profit (ttm)1.9M
EBITDA -21.34M
Net Income Avi to Common (ttm)-18.61M
Diluted EPS (ttm)-4.224
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.02M
Total Cash Per Share (mrq)1.61
Total Debt (mrq)19.13M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.71
Book Value Per Share (mrq)-0.31

Cash Flow Statement

Operating Cash Flow (ttm)-26.49M
Levered Free Cash Flow (ttm)-7.47M

Trading Information

Stock Price History

Beta 0.97
52-Week Change 3-96.80%
S&P500 52-Week Change 316.49%
52 Week High 35.800
52 Week Low 30.100
50-Day Moving Average 30.142
200-Day Moving Average 30.577

Share Statistics

Avg Vol (3 month) 343.97k
Avg Vol (10 day) 315.07k
Shares Outstanding 510.59M
Float 9.03M
% Held by Insiders 111.28%
% Held by Institutions 12.24%
Shares Short (Mar 29, 2018) 4648.84k
Short Ratio (Mar 29, 2018) 40.94
Short % of Float (Mar 29, 2018) 49.57%
Short % of Shares Outstanding (Mar 29, 2018) 48.20%
Shares Short (prior month Feb 28, 2018) 4504.41k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/20
Last Split Date 3Jan 19, 2018